337 related articles for article (PubMed ID: 26648205)
1. The anti-obesity drug orlistat promotes sensitivity to TRAIL by two different pathways in hormone-refractory prostate cancer cells.
Fujiwara J; Sowa Y; Horinaka M; Koyama M; Wakada M; Miki T; Sakai T
Int J Oncol; 2016 Feb; 48(2):854. PubMed ID: 26648205
[TBL] [Abstract][Full Text] [Related]
2. [Corrigendum] Brassinin induces G1 phase arrest through increase of p21 and p27 by inhibition of the phosphatidylinositol 3-kinase signaling pathway in human colon cancer cells.
Izutani Y; Yogosawa S; Sowa Y; Sakai T
Int J Oncol; 2016 Mar; 48(3):1305. PubMed ID: 26718100
[TBL] [Abstract][Full Text] [Related]
3. [Corrigendum] High PLK4 expression promotes tumor progression and induces epithelial‑mesenchymal transition by regulating the Wnt/β‑catenin signaling pathway in colorectal cancer.
Liao Z; Zhang H; Fan P; Huang Q; Dong K; Qi Y; Song J; Chen L; Liang H; Chen X; Zhang Z; Zhang B
Int J Oncol; 2022 Jan; 60(1):. PubMed ID: 34878151
[TBL] [Abstract][Full Text] [Related]
4. [Corrigendum] Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK‑mediated DR5 regulation in colorectal cancer.
Kim SL; Min IS; Park YR; Lee ST; Kim SW
Int J Oncol; 2019 May; 54(5):1897. PubMed ID: 30864690
[TBL] [Abstract][Full Text] [Related]
5. [Corrigendum] Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2.
Moro L; Arbini AA; Marra E; Greco M
Int J Oncol; 2016 Jun; 48(6):2722. PubMed ID: 27082245
[TBL] [Abstract][Full Text] [Related]
6. [Corrigendum] High PLK4 expression promotes tumor progression and induces epithelial‑mesenchymal transition by regulating the Wnt/β‑catenin signaling pathway in colorectal cancer.
Liao Z; Zhang H; Fan P; Huang Q; Dong K; Qi Y; Song J; Chen L; Liang H; Chen X; Zhang Z; Zhang B
Int J Oncol; 2021 Jun; 58(6):. PubMed ID: 33955524
[TBL] [Abstract][Full Text] [Related]
7. Corrigendum: Human β-defensin-3 inhibits migration of colon cancer cells via downregulation of metastasis-associated 1 family, member 2 expression.
Uraki S; Sugimoto K; Shiraki K; Tameda M; Inagaki Y; Ogura S; Kasai C; Nojiri K; Yoneda M; Yamamoto N; Takei Y; Nobori T; Ito M
Int J Oncol; 2015 Apr; 46(4):1858. PubMed ID: 25647176
[TBL] [Abstract][Full Text] [Related]
8. The anti-obesity drug orlistat promotes sensitivity to TRAIL by two different pathways in hormone-refractory prostate cancer cells.
Fujiwara J; Sowa Y; Horinaka M; Koyama M; Wakada M; Miki T; Sakai T
Int J Oncol; 2012 May; 40(5):1483-91. PubMed ID: 22328338
[TBL] [Abstract][Full Text] [Related]
9. Correction: Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential.
Semba S; Trapasso F; Fabbri M; McCorkell KA; Volinia S; Druck T; Iliopoulos D; Pekarsky Y; Ishii H; Garrison PN; Barnes LD; Croce CM; Huebner K
Oncogene; 2020 Mar; 39(10):2224-2226. PubMed ID: 31819168
[TBL] [Abstract][Full Text] [Related]
10. [Corrigendum] Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways.
Chen C; Chang YC; Lan MS; Breslin M
Int J Oncol; 2016 Aug; 49(2):847. PubMed ID: 27279381
[TBL] [Abstract][Full Text] [Related]
11. [Corrigendum] USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β‑catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma.
Ning Z; Wang A; Liang J; Xie Y; Liu J; Feng L; Yan Q; Wang Z
Int J Oncol; 2019 Nov; 55(5):1176. PubMed ID: 31485660
[TBL] [Abstract][Full Text] [Related]
12. [Erratum] circRNA_001275 upregulates Wnt7a expression by competitively sponging miR‑370‑3p to promote cisplatin resistance in esophageal cancer.
Zou FW; Yang SZ; Li WY; Liu CY; Liu XH; Hu CH; Liu ZH; Xu S
Int J Oncol; 2020 Dec; 57(6):1382. PubMed ID: 33174012
[TBL] [Abstract][Full Text] [Related]
13. [Corrigendum] Increased expression levels of ppGalNAc-T13 in lung cancers: Significance in the prognostic diagnosis.
Nogimori K; Hori T; Kawaguchi K; Fukui T; Mii S; Nakada H; Matsumoto Y; Yamauchi Y; Takahashi M; Furukawa K; Tetsuya O; Yokoi K; Hasegawa Y; Furukawa K
Int J Oncol; 2017 Feb; 50(2):746. PubMed ID: 27959390
[TBL] [Abstract][Full Text] [Related]
14. [Corrigendum] Genetic and epigenetic alterations are involved in the regulation of TPM1 in cholangiocarcinoma.
Yang W; Wang X; Zheng W; Li K; Liu H; Sun Y
Int J Oncol; 2017 Jan; 50(1):340. PubMed ID: 27779677
[TBL] [Abstract][Full Text] [Related]
15. [Corrigendum] Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer.
Gil EY; Jo UH; Jeong H; Whang YM; Woo OH; Cho KR; Seo JH; Kim A; Lee ES; Koh I; Kim YH; Park KH
Int J Oncol; 2017 Apr; 50(4):1455. PubMed ID: 28350046
[TBL] [Abstract][Full Text] [Related]
16. [Corrigendum] Functional analysis of Zyxin in cell migration and invasive potential of oral squamous cell carcinoma cells.
Yamamura M; Noguchi K; Nakano Y; Segawa E; Zushi Y; Takaoka K; Kishimoto H; Hashimoto-Tamaoki T; Urade M
Int J Oncol; 2016 Nov; 49(5):2188. PubMed ID: 27666023
[TBL] [Abstract][Full Text] [Related]
17. [Corrigendum] Protective effects of exendin‑4 on hypoxia/reoxygenation‑induced injury in H9c2 cells.
Lu K; Chang G; Ye L; Zhang P; Li Y; Zhang D
Mol Med Rep; 2020 Aug; 22(2):1090. PubMed ID: 32468031
[TBL] [Abstract][Full Text] [Related]
18. [Corrigendum] Bradykinin receptors and EphB2/EphrinB2 pathway in response to high glucose‑induced osteoblast dysfunction and hyperglycemia‑induced bone deterioration in mice.
Wu M; Ai W; Chen L; Zhao S; Liu E
Int J Mol Med; 2019 Apr; 43(4):1920. PubMed ID: 30816429
[TBL] [Abstract][Full Text] [Related]
19. [Corrigendum] Distinct expression of C4.4A in colorectal cancer detected by different antibodies.
Yamamoto H; Oshiro R; Ohtsuka M; Uemura M; Haraguchi N; Nishimura J; Takemasa I; Mizushima T; Doki Y; Mori M
Int J Oncol; 2016 Nov; 49(5):2186. PubMed ID: 27634111
[TBL] [Abstract][Full Text] [Related]
20. [Corrigendum] Preventive effect of caffeine and curcumin on hepato-carcinogenesis in diethylnitrosamine-induced rats.
Fujise Y; Okano J; Nagahara T; Abe R; Imamoto R; Murawaki Y
Int J Oncol; 2016 Sep; 49(3):1259. PubMed ID: 27314753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
